Results 121 to 130 of about 15,419 (219)

Incremental health care resource utilization and expenditures associated with autosomal dominant polycystic kidney disease

ClinicoEconomics and Outcomes Research, 2018
Neeraj N Iyer,1 Nicholas J Vendetti,2 Daniel I Levy,3 Jack Mardekian,4 Marko A Mychaskiw,2 Joseph Thomas III1 1Regenstrief Center for Healthcare Engineering and Center for Health Outcomes Research and Policy, College of Pharmacy, Purdue University, West ...
Iyer NN, Vendetti NJ, Levy DI, Mardekian J, Mychaskiw MA, Thomas III J   +5 more
doaj  

Molecular genetic diagnosis of autosomal dominant polycystic kidney disease - A systematic review. [PDF]

Glob Med Genet
Ciantar N, Said E.
europepmc   +1 more source

SAR-Guided Scaffold Innovation of Selective V₂R Antagonists: Therapeutic Frontiers in ADPKD. [PDF]

ACS Med Chem Lett
Shi H, Li Y, Liang SH.
europepmc   +1 more source

IFT140-related ADPKD

Kidney International Reports
Catania M., Mancassola G., De Rosa L. I., Kola K., Pepe G., Manunta P., Vezzoli G., Carrera P., Sciarrone Alibrandi M. T.   +8 more
openaire   +3 more sources

Progressive endocannabinoid system dysregulation in autosomal dominant polycystic kidney disease. [PDF]

Mol Med
Betkar S, Nemirovski A, Ruppo S, Hinden L, Tam J.   +4 more
europepmc   +1 more source

Overweight and Obesity Are Associated with Lower Renal Blood Flow in Autosomal Dominant Polycystic Kidney Disease. [PDF]

Kidney Blood Press Res
Birznieks CL, Wang W, Steele C, You Z, Gitomer B, Chonchol M, Nowak KL.   +6 more
europepmc   +1 more source

Defining Cardiac Dysfunction in ADPKD

Kidney360, 2023
openaire   +2 more sources

Retroperitoneoscopic Nephrectomy at the Time of Kidney Transplantation for Autosomal Dominant Polycystic Kidney Disease: Safety, Efficacy, Feasibility, and Cosmetic Outcomes. [PDF]

Transplant Direct
Ohyama T, Nishida S, Minamisono K, Nakao T, Iwami D.   +4 more
europepmc   +1 more source

Response to the Letter to the Editor Entitled "The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD". [PDF]

Kidney Int Rep
Wang J, Lee SY, Chao CT.
europepmc   +1 more source

The Weight of Disease, the Loss Within: Rethinking Frailty Assessment in ADPKD. [PDF]

Kidney Int Rep
Paolisi M, Bianca P, De Rosa LI, Catania M, Kola K, Pisoni MB, Maiucchi P, Vezzoli G, Sciarrone Alibrandi MT.   +8 more
europepmc   +1 more source